EasyManua.ls Logo

CONTOUR NEXT LINK 2.4 - Support and Warranty Information; Available Supplies and Parts; Manufacturers Warranty

CONTOUR NEXT LINK 2.4
39 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
67
TECHNICAL
& CARE
Warranty
Manufacturer’s Warranty: Ascensia Diabetes Care warrants to the original purchaser that
this instrument will be free from defects in materials and workmanship for 5 years from
the date of original purchase (except as noted below). During the stated 5-year period,
Ascensia Diabetes Care shall, at no charge, replace a unit found to be defective with an
equivalent or current version of the owner’s model.
Limitations of Warranty: This warranty is subject to the following exceptions and
limitations:
1. A 90-day warranty only will be extended for consumable parts and/or accessories.
2. This warranty is limited to replacement due to defects in parts or workmanship.
Ascensia Diabetes Care shall not be required to replace any units that malfunction or
are damaged due to abuse, accidents, alteration, misuse, neglect, maintenance by
someone other than Ascensia Diabetes Care, or failure to operate the instrument in
accordance with instructions. Further, Ascensia Diabetes Care assumes no liability for
malfunction of or damage to Ascensia Diabetes Care instruments caused by the use
of test strips or control solution other than the appropriate products recommended by
Ascensia Diabetes Care (i.e., C
ONTOUR
®
N
EXT
test strips and C
ONTOUR
®
N
EXT
control
solutions).
3. Ascensia Diabetes Care reserves the right to make changes in the design of this
instrument without obligation to incorporate such changes into previously manufactured
instruments.
4. Ascensia Diabetes Care has not validated the performance of the C
ONTOUR
®
N
EXT
LINK 2.4
blood glucose meter when used with any test strips other than C
ONTOUR
®
N
EXT
test
strips, and therefore does not warrant the performance of the C
ONTOUR
N
EXT
LINK 2.4
meter when used with any test strips other than C
ONTOUR
®
N
EXT
test strips or when the
C
ONTOUR
N
EXT
test strip is altered or modified in any manner.
5. Ascensia Diabetes Care makes no warranty regarding the performance of the
C
ONTOUR
N
EXT
LINK 2.4 meter or test results when used with any control solution other
than C
ONTOUR
®
N
EXT
control solution.
6. Ascensia Diabetes Care makes no warranty regarding the performance of the
C
ONTOUR
®
N
EXT
LINK 2.4 meter or test results when used with any software other than
the C
ONTOUR
TM
D
IABETES
app (where supported) or the G
LUCOFACTS
®
D
ELUXE
diabetes
management software (where supported) from ASCENSIA DIABETES CARE.
ASCENSIA DIABETES CARE MAKES NO OTHER EXPRESS OR IMPLIED WARRANTY FOR
THIS PRODUCT. THE OPTION OF REPLACEMENT, DESCRIBED ABOVE, IS THE ONLY
OBLIGATION OF ASCENSIA DIABETES CARE UNDER THIS WARRANTY.
IN NO EVENT SHALL ASCENSIA DIABETES CARE BE LIABLE FOR INDIRECT, SPECIAL
OR CONSEQUENTIAL DAMAGES, EVEN IF ASCENSIA DIABETES CARE HAS BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
Some States do not allow the exclusion or limitation of incidental or consequential
damages, so the above limitation or exclusion may not apply to you. This warranty gives
you specific legal rights and you may also have other rights which vary from State to State.
For warranty service: Purchaser must contact Ascensia Diabetes Care Customer Service
for assistance and/or instructions for obtaining service of this instrument. See the back
cover for contact information.
Warranty
85587269_CntrNextLINK_2_4_UG_EN_FpBp_v4.indd 67 11/18/16 9:03 AM
TECHNICAL
& CARE
66
Supplies
When calling or writing for supplies be sure to include the name of the replacement part or
accessory item.
Replacement Parts / Items
References
1. Wickham NWR, et al. Unreliability of capillary blood glucose in peripheral vascular
disease. Practical Diabetes.1986;3(2):100.
2. Atkin SH, et al. Fingerstick glucose determination in shock. Annals of Internal Medicine.
1991;114(12):1020-1024.
3. Desachy A, et al. Accuracy of bedside glucometry in critically ill patients: influence of
clinical characteristics and perfusion index. Mayo Clinic Proceedings. 2008;83(4):400-405.
4. US Food and Drug Administration. Use of fingerstick devices on more than one person
poses risk for transmitting bloodborne pathogens: initial communication. US Department
of Health and Human Services; update 11/29/2010. http://www.fda.gov/MedicalDevices/
Safety/AlertsandNotices/ucm224025.htm
5. Centers for Disease Control and Prevention. CDC clinical reminder: use of fingerstick
devices on more than one person poses risk for transmitting bloodborne pathogens.
US Department of Health and Human Services; 8/23/2010. http://www.cdc.gov/
injectionsafety/Fingerstick-DevicesBGM.html
6. American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes
Care. 2014;37(supplement 1);S14.
7. Cryer PE, Davis SN. Hypoglycemia. In: Kasper D, et al, editors. Harrison’s Principles of
Internal Medicine. 19th edition. New York, NY: McGraw Hill; 2015.
8. Data on file, Ascensia Diabetes Care.
9. Parkes J.L. et al. A new consensus error grid to evaluate the clinical significance of
inaccuracies in the measurement of blood-glucose. Diabetes Care. 2000;23(8):
1143-1148.
10. Burtis CA, Ashwood ER, editors. Tietz Fundamentals of Clinical Chemistry. 5th edition.
Philadelphia, PA: WB Saunders Co; 2001;444.
11. Bailey T, Klaff LJ, Wallace JF, et al. Accuracy, precision, and user performance evaluation
of the C
ONTOUR
®
NEXT LINK 2.4 blood glucose monitoring system. Poster presented
at: 7th International Conference on Advanced Technologies & Treatments for Diabetes;
February 5-8, 2014; Vienna, Austria.
12. Greene C, Brown D, Wallace JF, et al. Comparative accuracy of 3 blood glucose
monitoring systems that communicate with an insulin pump. Endocr Pract.
2014;20(10):1016-1021.
13. Pardo S, Pflug B, Dunne N, Simmons DA. Comparison of bolus insulin dose error
distributions based on results from 2 clinical trials of blood glucose monitoring systems.
Presented at: 14th Annual Meeting of the Diabetes Technology Society; November 6-8,
2014; Bethesda, MD.
• CONTOUR
®
NEXT LINK 2.4 user guide
C
ONTOUR NEXT LINK 2.4 quick reference
guide
• USB extension cable
• USB cap
• Wall charger
• C
ONTOUR
®
NEXT test strips
• C
ONTOUR
®
NEXT control solution
• Lancing device
• Lancets
Check the website
www.diabetes.ascensia.com
for any meter updates or
G
LUCOFACTS
®
DELUXE updates.
To order parts, contact Customer Service.
Please see back cover for contact
information.
Supplies
85587269_CntrNextLINK_2_4_UG_EN_FpBp_v4.indd 66 11/18/16 9:03 AM
67
TECHNICAL
& CARE
Warranty
Manufacturer’s Warranty: Ascensia Diabetes Care warrants to the original purchaser that
this instrument will be free from defects in materials and workmanship for 5 years from
the date of original purchase (except as noted below). During the stated 5-year period,
Ascensia Diabetes Care shall, at no charge, replace a unit found to be defective with an
equivalent or current version of the owner’s model.
Limitations of Warranty: This warranty is subject to the following exceptions and
limitations:
1. A 90-day warranty only will be extended for consumable parts and/or accessories.
2. This warranty is limited to replacement due to defects in parts or workmanship.
Ascensia Diabetes Care shall not be required to replace any units that malfunction or
are damaged due to abuse, accidents, alteration, misuse, neglect, maintenance by
someone other than Ascensia Diabetes Care, or failure to operate the instrument in
accordance with instructions. Further, Ascensia Diabetes Care assumes no liability for
malfunction of or damage to Ascensia Diabetes Care instruments caused by the use
of test strips or control solution other than the appropriate products recommended by
Ascensia Diabetes Care (i.e., C
ONTOUR
®
N
EXT
test strips and C
ONTOUR
®
N
EXT
control
solutions).
3. Ascensia Diabetes Care reserves the right to make changes in the design of this
instrument without obligation to incorporate such changes into previously manufactured
instruments.
4. Ascensia Diabetes Care has not validated the performance of the C
ONTOUR
®
N
EXT
LINK 2.4
blood glucose meter when used with any test strips other than C
ONTOUR
®
N
EXT
test
strips, and therefore does not warrant the performance of the C
ONTOUR
N
EXT
LINK 2.4
meter when used with any test strips other than C
ONTOUR
®
N
EXT
test strips or when the
C
ONTOUR
N
EXT
test strip is altered or modified in any manner.
5. Ascensia Diabetes Care makes no warranty regarding the performance of the
C
ONTOUR
N
EXT
LINK 2.4 meter or test results when used with any control solution other
than C
ONTOUR
®
N
EXT
control solution.
6. Ascensia Diabetes Care makes no warranty regarding the performance of the
C
ONTOUR
®
N
EXT
LINK 2.4 meter or test results when used with any software other than
the C
ONTOUR
TM
D
IABETES
app (where supported) or the G
LUCOFACTS
®
D
ELUXE
diabetes
management software (where supported) from ASCENSIA DIABETES CARE.
ASCENSIA DIABETES CARE MAKES NO OTHER EXPRESS OR IMPLIED WARRANTY FOR
THIS PRODUCT. THE OPTION OF REPLACEMENT, DESCRIBED ABOVE, IS THE ONLY
OBLIGATION OF ASCENSIA DIABETES CARE UNDER THIS WARRANTY.
IN NO EVENT SHALL ASCENSIA DIABETES CARE BE LIABLE FOR INDIRECT, SPECIAL
OR CONSEQUENTIAL DAMAGES, EVEN IF ASCENSIA DIABETES CARE HAS BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
Some States do not allow the exclusion or limitation of incidental or consequential
damages, so the above limitation or exclusion may not apply to you. This warranty gives
you specific legal rights and you may also have other rights which vary from State to State.
For warranty service: Purchaser must contact Ascensia Diabetes Care Customer Service
for assistance and/or instructions for obtaining service of this instrument. See the back
cover for contact information.
Warranty
85587269_CntrNextLINK_2_4_UG_EN_FpBp_v4.indd 67 11/18/16 9:03 AM
TECHNICAL
& CARE
66
Supplies
When calling or writing for supplies be sure to include the name of the replacement part or
accessory item.
Replacement Parts / Items
References
1. Wickham NWR, et al. Unreliability of capillary blood glucose in peripheral vascular
disease. Practical Diabetes.1986;3(2):100.
2. Atkin SH, et al. Fingerstick glucose determination in shock. Annals of Internal Medicine.
1991;114(12):1020-1024.
3. Desachy A, et al. Accuracy of bedside glucometry in critically ill patients: influence of
clinical characteristics and perfusion index. Mayo Clinic Proceedings. 2008;83(4):400-405.
4. US Food and Drug Administration. Use of fingerstick devices on more than one person
poses risk for transmitting bloodborne pathogens: initial communication. US Department
of Health and Human Services; update 11/29/2010. http://www.fda.gov/MedicalDevices/
Safety/AlertsandNotices/ucm224025.htm
5. Centers for Disease Control and Prevention. CDC clinical reminder: use of fingerstick
devices on more than one person poses risk for transmitting bloodborne pathogens.
US Department of Health and Human Services; 8/23/2010. http://www.cdc.gov/
injectionsafety/Fingerstick-DevicesBGM.html
6. American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes
Care. 2014;37(supplement 1);S14.
7. Cryer PE, Davis SN. Hypoglycemia. In: Kasper D, et al, editors. Harrison’s Principles of
Internal Medicine. 19th edition. New York, NY: McGraw Hill; 2015.
8. Data on file, Ascensia Diabetes Care.
9. Parkes J.L. et al. A new consensus error grid to evaluate the clinical significance of
inaccuracies in the measurement of blood-glucose. Diabetes Care. 2000;23(8):
1143-1148.
10. Burtis CA, Ashwood ER, editors. Tietz Fundamentals of Clinical Chemistry. 5th edition.
Philadelphia, PA: WB Saunders Co; 2001;444.
11. Bailey T, Klaff LJ, Wallace JF, et al. Accuracy, precision, and user performance evaluation
of the C
ONTOUR
®
NEXT LINK 2.4 blood glucose monitoring system. Poster presented
at: 7th International Conference on Advanced Technologies & Treatments for Diabetes;
February 5-8, 2014; Vienna, Austria.
12. Greene C, Brown D, Wallace JF, et al. Comparative accuracy of 3 blood glucose
monitoring systems that communicate with an insulin pump. Endocr Pract.
2014;20(10):1016-1021.
13. Pardo S, Pflug B, Dunne N, Simmons DA. Comparison of bolus insulin dose error
distributions based on results from 2 clinical trials of blood glucose monitoring systems.
Presented at: 14th Annual Meeting of the Diabetes Technology Society; November 6-8,
2014; Bethesda, MD.
CONTOUR
®
NEXT LINK 2.4 user guide
C
ONTOUR NEXT LINK 2.4 quick reference
guide
USB extension cable
USB cap
Wall charger
C
ONTOUR
®
NEXT test strips
C
ONTOUR
®
NEXT control solution
Lancing device
Lancets
Check the website
www.diabetes.ascensia.com
for any meter updates or
G
LUCOFACTS
®
DELUXE updates.
To order parts, contact Customer Service.
Please see back cover for contact
information.
Supplies
85587269_CntrNextLINK_2_4_UG_EN_FpBp_v4.indd 66 11/18/16 9:03 AM
85587269_CntrNextLINK_2_4_UG_EN_FpBp_v5_UnMaskedPlaced.pdf:70

Other manuals for CONTOUR NEXT LINK 2.4

Related product manuals